Home > Products > Pharmaceutical R&D Materials > Functional Building Blocks > 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine
4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine structure, CAS 1401436-95-0

4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine

CAS Number1401436-95-0

Synonyms

Molecular FormulaC31H38O1N8F2

Molecular Weight576.69

Purity

Density

Boiling Point729.2±70.0 °C(Predicted)

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-2187517 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 1401436-95-0 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number1401436-95-0
Catalog No.2A-2187517
Chinese NameZandelisib
Molecular FormulaC31H38O1N8F2
Molecular Weight576.69
Boiling Point729.2±70.0 °C(Predicted)
Storage Condition-20°C
ApplicationZandelisib is a PI3K inhibitor with an IC50 value of 3.5 nM for selectively inhibiting p110δ. For detailed information, please refer to compound 1 in the patent document WO2019183226 A1. Zandelisib ha
PubChem ID152228767
MDL NumberMFCD32710288
InChIInChI=1S/C31H38F2N8O/c1-31(2,20-22-8-4-5-9-23(22)21-12-14-39(3)15-13-21)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-25-11-7-6-10-24(25)34-27(41)26(32)33/h4-11,21,26H,12-20H2,1-3H3,(H,35,36,37,38)
InChI KeyWPFUFWIHMYZXSF-UHFFFAOYSA-N
Transport InfoProduct name: Zandelisib
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA